W. Alexander

发表

The multi-organ origin of interleukin-5 in the mouse

T. Willson, D. Metcalf, S. Mifsud, 2001, Leukemia.

Two distinct types of murine blast colony-forming cells are multipotential hematopoietic precursors

C. D. de Graaf, M. Kauppi, S. Loughran, 2008, Proceedings of the National Academy of Sciences.

Expression of functional c‐kit receptors rescues the genetic defect of W mutant mast cells.

E. Wagner, W. Alexander, S. Lyman, 1991, The EMBO journal.

The biological consequences of excess GM-CSF levels in transgenic mice also lacking high-affinity receptors for GM-CSF

L. Robb, D. Metcalf, S. Mifsud, 1998, Leukemia.

A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation.

G. Mann, A. Burgess, F. Walker, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Transgenic mouse models for hematopoietic tumorigenesis.

D. Vaux, I. Hariharan, W. Alexander, 1988, Current topics in microbiology and immunology.

Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.

A. Roberts, S. Kimura, D. Metcalf, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Point mutations within a dimer interface homology domain of c‐Mpl induce constitutive receptor activity and tumorigenicity.

W. Alexander, A. Dunn, D. Metcalf, 1995, The EMBO journal.

BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells

Stefan P. Glaser, A. Strasser, P. P. Sharp, 2016, Leukemia.

SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function

T. Fioretos, J. Melo, M. Ehinger, 2011, Leukemia.

SOCS 2 is dispensable for BCR / ABL 1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function

T. Fioretos, M. Ehinger, D. Bryder, 2012 .

The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene.

D. Metcalf, L. Hartley, S. Mifsud, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1

A. Elefanty, W. Alexander, D. Hilton, 1999, Leukemia.